Stockreport

BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates

BioNTech SE - American Depositary Shares  (BNTX) 
PDF First COVID-19-related clinical trial to start in GermanyInitial dose escalation phase to target dose range of 1µg to 100µg Clinical supply from BioNTech’s GMP-certified [Read more]